Bukwang Pharmaceutical Co (XKRX:003000) Total Stockholders Equity : ₩224,473 Mil (As of Sep. 2024)

View and export this data going back to 1988. Start your Free Trial

What is Bukwang Pharmaceutical Co Total Stockholders Equity?

Bukwang Pharmaceutical Co's Total Stockholders Equity for the quarter that ended in Sep. 2024 was ₩224,473 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Bukwang Pharmaceutical Co's Book Value per Share for the quarter that ended in Sep. 2024 was ₩3,279.15. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Bukwang Pharmaceutical Co's Debt-to-Equity for the quarter that ended in Sep. 2024 was 0.35.

Bukwang Pharmaceutical Co Total Stockholders Equity Historical Data

The historical data trend for Bukwang Pharmaceutical Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bukwang Pharmaceutical Co Total Stockholders Equity Chart

Bukwang Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

326,246.22

258,499.09

269,607.67

263,217.37

226,311.36

Bukwang Pharmaceutical Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Stockholders Equity	Get a 7-Day Free Trial															243,365.45	226,311.36	225,109.92	224,705.68	224,473.26

Bukwang Pharmaceutical Co (XKRX:003000) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Bukwang Pharmaceutical Co's Book Value per Share for the quarter that ended in Sep. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(224473.263	-	0)	/	68.4547
	=	3,279.15

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Bukwang Pharmaceutical Co's Debt-to-Equity for the quarter that ended in Sep. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(157.737	+	79137.314)	/	224473.263
	=	0.35

Bukwang Pharmaceutical Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Bukwang Pharmaceutical Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Bukwang Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bukwang Pharmaceutical Co Ltd (XKRX:003000) » Definitions » Total Stockholders Equity

Traded in Other Exchanges

N/A

Address

398-1 Daebang-Dong, Dongjak-Gu, Seoul, KOR

Website

http://www.bukwang.co.kr

Bukwang Pharmaceutical Co Ltd manufactures and markets medicines for diabetes, hepatitis B, anticancer and psychiatry. The Company's OTC products focus on dental treatment. The company also engages in venture business and bio engineering.

Bukwang Pharmaceutical Co Headlines

No Headlines